CMP
CMP
CMP - Cipla Medpro - Investor Update Session
CIPLA MEDPRO SOUTH AFRICA LIMITED
(formerly Enaleni Pharmaceuticals Limited)
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(ISIN Number: ZAE000128179 Share Code: CMP)
("Cipla Medpro" or "the Group")
INVESTOR UPDATE SESSION
Shareholders are advised that the management of Cipla Medpro hosted an Investor
Update session in Cape Town today. The Group`s strategy and operations inter
alia were discussed. No new material information, which is not in the public
domain, was released. A copy of the presentation can be downloaded from
www.ciplamedsa.co.za.
Johannesburg
30 June 2009
Investment bank and sponsor
Nedbank Capital
Date: 30/06/2009 14:19:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
